<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.5-a.1'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//nxtin.health/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://nxtin.health/2026/11/16/ai-powered-protein-design-how-biomatter-is-transforming-global-biotech-and-sustainability/</loc>
  <lastmod>2026-11-16T15:39:36Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>AI-powered protein design: how Biomatter is transforming global biotech and sustainability</news:title>
   <news:publication_date>2026-11-16T15:39:36Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/why-cell-and-gene-therapy-manufacturing-is-expanding-in-europe/</loc>
  <lastmod>2026-11-16T15:39:09Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Why cell and gene therapy manufacturing is expanding in Europe</news:title>
   <news:publication_date>2026-11-16T15:39:09Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/5-biotech-companies-in-lithuania-to-watch-in-2026/</loc>
  <lastmod>2026-11-16T15:38:37Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>5 biotech companies in Lithuania to watch in 2026</news:title>
   <news:publication_date>2026-11-16T15:38:37Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/why-investors-choose-lithuania/</loc>
  <lastmod>2026-11-16T15:38:01Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Why investors choose Lithuania</news:title>
   <news:publication_date>2026-11-16T15:38:01Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/lithuanias-health-innovation-from-gene-editing-to-robotic-stroke-care-2/</loc>
  <lastmod>2026-11-16T15:37:30Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Lithuania’s health innovation: from gene editing to robotic stroke care</news:title>
   <news:publication_date>2026-11-16T15:37:30Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/healthcare-without-an-expiry-date-jean-claude-muscat-on-future-proof-hospitals/</loc>
  <lastmod>2026-11-16T12:30:42Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Healthcare without an expiry date: Jean-Claude Muscat on future-proof hospitals</news:title>
   <news:publication_date>2026-11-16T12:30:40Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/fresenius-and-wuxi-biologics-enter-exclusive-development-agreement-to-expand-biosimilars-pipeline/</loc>
  <lastmod>2026-11-16T12:02:59Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Fresenius and WuXi Biologics enter exclusive development agreement to expand biosimilars pipeline</news:title>
   <news:publication_date>2026-11-16T12:02:57Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/sofinnova-partners-closes-e725m-crossover-ii-fund/</loc>
  <lastmod>2026-11-16T11:41:38Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Sofinnova Partners closes €725M Crossover II Fund</news:title>
   <news:publication_date>2026-11-16T11:41:36Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/teleclinic-expands-into-switzerland-through-acquisition-of-medi24/</loc>
  <lastmod>2026-11-16T12:51:45Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>TeleClinic expands into Switzerland through acquisition of Medi24</news:title>
   <news:publication_date>2026-11-16T10:47:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/eu-and-singapore-team-up-on-medicines-and-medical-device-safety/</loc>
  <lastmod>2026-11-16T12:44:56Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>EU and Singapore team up on medicines and medical device safety</news:title>
   <news:publication_date>2026-11-16T08:44:24Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/htl-biotechnology-launches-htl8-a-production-unit-dedicated-to-pharmaceutical-grade-polynucleotides/</loc>
  <lastmod>2026-11-16T10:18:49Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>HTL Biotechnology launches HTL8, a production unit dedicated to pharmaceutical-grade polynucleotides</news:title>
   <news:publication_date>2026-11-16T08:39:09Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/building-cardiolyse-the-distance-from-a-good-algorithm-to-a-doctors-desk/</loc>
  <lastmod>2026-11-16T08:24:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Building Cardiolyse - the distance from a good algorithm to a doctor&amp;#039;s desk</news:title>
   <news:publication_date>2026-11-16T08:23:58Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/16/european-commission-publishes-joint-clinical-assessment-report-on-new-breast-cancer-medicine/</loc>
  <lastmod>2026-11-16T08:02:02Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>European Commission publishes joint clinical assessment report on new breast cancer medicine</news:title>
   <news:publication_date>2026-11-16T08:02:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://nxtin.health/2026/11/15/the-eu-wants-to-reach-zero-road-deaths-by-2050/</loc>
  <lastmod>2026-11-15T15:06:01Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>NXTin health</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>The EU wants to reach zero road deaths by 2050</news:title>
   <news:publication_date>2026-11-15T15:05:58Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
